Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zura Bio LtdZURA · Entity 5413 | Chief Legal Officer | April 01, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zura Bio Ltd
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.03 · Expires 2036-04-01 | Direct | 425,700 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 425,700 · Balance 425,700 F1: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 22:00 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantEmployee Share Option (Right to Buy) · Derivative | 425,700 | $0.00 Strike: $6.03 | $0.00 |
DisclosureSEC source: 0001965590-26-000002 · form4-04022026_060414.xml · derivative · entry 1 Davis Kim · CIK 0001965590 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 425,700 Underlying: Class A Ordinary Shares · 425,700 shares Expires 2036-04-01 F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:00 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantEmployee Share Option (Right to Buy) · Derivative | 488,800 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001415889-25-006199 · form4-03032025_100340.xml · derivative · entry 1 Davis Kim · CIK 0001965590 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,800 Underlying: Class A Ordinary Shares · 488,800 shares Expires 2035-02-27 F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| September 16, 2024 Filed Dec 31, 2024 21:15 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantClass A Ordinary Shares | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-030312 · form4-12312024_041201.xml · nonDerivative · entry 2 Davis Kim · CIK 0001965590 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Member Disclosed balance after: 1,500 F1 · shares: Represents a restricted stock unit award, which vested in full immediately upon grant. F2 · ownership.nature: The securities are held by the Reporting Person's family member. The Reporting Person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 22:10 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantEmployee Share Option (Right to Buy) · Derivative | 420,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001415889-24-017863 · form4-06212024_060612.xml · derivative · entry 1 Davis Kim · CIK 0001965590 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,000 Underlying: Class A Ordinary Shares · 420,000 shares Expires 2034-06-18 F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| October 01, 2023 Filed Dec 31, 2024 21:15 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantClass A Ordinary Shares | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-030312 · form4-12312024_041201.xml · nonDerivative · entry 1 Davis Kim · CIK 0001965590 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Member Disclosed balance after: 500 F1 · shares: Represents a restricted stock unit award, which vested in full immediately upon grant. F2 · ownership.nature: The securities are held by the Reporting Person's family member. The Reporting Person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 18, 2023 Filed May 23, 2023 01:16 UTC | Zura Bio Ltd ZURA · Entity 5413 | GrantClass A Ordinary Shares | 492,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-063313 · tm2316481-3_4seq1.xml · nonDerivative · entry 1 Davis Kim · CIK 0001965590 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,381 F1 · shares: The Reporting Person was granted an award of 492,381 Restricted Share Units ("RSUs") on May 18, 2023 (the "Grant Date"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.